Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Molecules (Basel, Switzerland)|October 27, 2022
Why Matter Matters: Fast-Tracking <i>Mycobacterium abscessus</i> Drug DiscoveryUday S Ganapathy, Thomas DickAntimicrobial Agents and Chemotherapy|July 19, 2021
Epetraborole Is Active against Mycobacterium abscessusUday S Ganapathy, Martin Gengenbacher, Thomas DickExpert Opinion on Drug Discovery|June 15, 2019
Repositioning rifamycins for Mycobacterium abscessus lung diseaseUday S Ganapathy, Véronique Dartois, Thomas DickAntibiotics (Basel, Switzerland)|May 24, 2024
Broad-Spectrum In Vitro Activity of <i>N</i>α-Aroyl-<i>N</i>-Aryl-Phenylalanine Amides against Non-Tuberculous Mycobacteria and Comparative Analysis of RNA PolymerasesMarkus Lang, Uday S Ganapathy, Rana Abdelaziz, et al.Microbiology Spectrum|September 8, 2023
Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycinsUday S Ganapathy, Tian Lan, Véronique Dartois, et al.Antimicrobial Agents and Chemotherapy|January 23, 2020
TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessusJickky Palmae Sarathy, Uday S Ganapathy, Matthew D Zimmerman, et al.Chemmedchem|February 8, 2024
Synthesis and in vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine AmidesMarkus Lang, Uday S Ganapathy, Lea Mann, et al.Microbiology Spectrum|November 15, 2022
<i>In Vitro</i> Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessusLea Mann, Uday S Ganapathy, Rana Abdelaziz, et al.Antimicrobial Agents and Chemotherapy|July 26, 2023
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant <i>M. abscessus</i> in caseum surrogateMin Xie, Uday S Ganapathy, Tian Lan, et al.ACS Infectious Diseases|May 1, 2018
Compartment-Specific Labeling of Bacterial Periplasmic Proteins by Peroxidase-Mediated BiotinylationUday S Ganapathy, Lu Bai, Linpeng Wei, et al.Pageof 2